Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oncogene

Showing results (621-630 of 22,563) with videos related to

Pageof 2,257
Sort By:
Oncogene|May 9, 2007
Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signalingK Shtiegman, B S Kochupurakkal, Y Zwang, et al.
Oncogene|May 9, 2007
Differential nuclear localization and kinase activity of alternative ErbB4 intracellular domainsM Sundvall, L Peri, J A Määttä, et al.
Oncogene|May 9, 2007
Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1J Lin, T Sun, L Ji, et al.
Oncogene|May 9, 2007
The autophagic inducer smARF interacts with and is stabilized by the mitochondrial p32 proteinS Reef, O Shifman, M Oren, et al.
Oncogene|May 9, 2007
Targeting the function of the HER2 oncogene in human cancer therapeuticsM M Moasser
Oncogene|May 9, 2007
The VHL tumor suppressor inhibits expression of the IGF1R and its loss induces IGF1R upregulation in human clear cell renal carcinomaJ S P Yuen, M E Cockman, M Sullivan, et al.
Oncogene|June 30, 2007
Egr-1 abrogates the E2F-1 block in terminal myeloid differentiation and suppresses leukemiaJ D Gibbs, D A Liebermann, B Hoffman
Oncogene|June 30, 2007
Downregulation of c-FLIP promotes caspase-dependent JNK activation and reactive oxygen species accumulation in tumor cellsA Nakajima, Y Kojima, M Nakayama, et al.
Oncogene|June 30, 2007
Therapeutic potential of CDK inhibitor NU2058 in androgen-independent prostate cancerA C Rigas, C N Robson, N J Curtin
Oncogene|June 30, 2007
Human RNA polymerase II-associated factor complex: dysregulation in cancerK Chaudhary, S Deb, N Moniaux, et al.
Pageof 2,257

Showing results (621-630 of 22,563) with videos related to

Sort By:
Pageof 2,257
Oncogene|May 9, 2007
Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signalingK Shtiegman, B S Kochupurakkal, Y Zwang, et al.
Oncogene|May 9, 2007
Differential nuclear localization and kinase activity of alternative ErbB4 intracellular domainsM Sundvall, L Peri, J A Määttä, et al.
Oncogene|May 9, 2007
Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1J Lin, T Sun, L Ji, et al.
Oncogene|May 9, 2007
The autophagic inducer smARF interacts with and is stabilized by the mitochondrial p32 proteinS Reef, O Shifman, M Oren, et al.
Oncogene|May 9, 2007
Targeting the function of the HER2 oncogene in human cancer therapeuticsM M Moasser
Oncogene|May 9, 2007
The VHL tumor suppressor inhibits expression of the IGF1R and its loss induces IGF1R upregulation in human clear cell renal carcinomaJ S P Yuen, M E Cockman, M Sullivan, et al.
Oncogene|June 30, 2007
Egr-1 abrogates the E2F-1 block in terminal myeloid differentiation and suppresses leukemiaJ D Gibbs, D A Liebermann, B Hoffman
Oncogene|June 30, 2007
Downregulation of c-FLIP promotes caspase-dependent JNK activation and reactive oxygen species accumulation in tumor cellsA Nakajima, Y Kojima, M Nakayama, et al.
Oncogene|June 30, 2007
Therapeutic potential of CDK inhibitor NU2058 in androgen-independent prostate cancerA C Rigas, C N Robson, N J Curtin
Oncogene|June 30, 2007
Human RNA polymerase II-associated factor complex: dysregulation in cancerK Chaudhary, S Deb, N Moniaux, et al.
Pageof 2,257